Home > Press > FEI Sells Phenom™ Product Line
Abstract:
FEI Company (NASDAQ: FEIC) announced that Phenom-World, a majority-owned subsidiary of NTS Group B.V. (NTS) of Eindhoven, The Netherlands, has acquired FEI's Phenom™ product line. NTS has been FEI's manufacturing partner and was closely involved with the development of the innovative desktop scanning electron microscope before it was introduced in 2007. NTS will continue to manufacture the product, and Phenom-World will assume responsibility for marketing, sales and distribution of the product worldwide, as well as service and warranty repairs for the installed base.
FEI will retain a minority position in Phenom-World and will retain certain related intellectual property. FEI expects this transaction will have a minimal impact on its 2009 fourth quarter earnings and will have a modest positive impact in 2010. Terms of the transaction were not disclosed.
"This transaction is consistent with our division strategy of focusing on value-added solutions for specific industries and groups of customers such as natural resources," said Paul Scagnetti, vice president and general manager of FEI's Industry market division. "As we continue to develop individual applications, we will be able to purchase Phenoms from Phenom-World when it is appropriate for our customer needs. NTS will combine its manufacturing and engineering strengths with marketing and distribution of the product."
####
About FEI Company
FEI (Nasdaq: FEIC) is a leading diversified scientific instruments company. It is a premier provider of electron and ion-beam microscopes and tools for nanoscale applications across many industries: industrial and academic materials research, life sciences, semiconductors, data storage, natural resources and more. With a 60-year history of technological innovation and leadership, FEI has set the performance standard in transmission electron microscopes (TEM), scanning electron microscopes (SEM) and DualBeams™, which combine a SEM with a focused ion beam (FIB). FEI’s imaging systems provide 3D characterization, analysis and modification/prototyping with resolutions down to the sub-Ångström (one-tenth of a nanometer) level. FEI’s NanoPorts in North America, Europe and Asia provide centers of technical excellence where its world-class community of customers and specialists collaborate. FEI has approximately 1800 employees and sales and service operations in more than 50 countries around the world.
Safe Harbor Statement
This news release contains forward-looking statements that include the impact on FEI’s financial results due to the sale of its Phenom product line and NTS Group’s assumption of future sales and distribution of the product line. Factors that could affect these forward-looking statements include, but are not limited to, failure of the market for Phenom products to develop as expected and unexpected costs or asset valuation issues. Please also refer to our Form 10-K, Forms 10-Q, Forms 8-K and other filings with the U.S. Securities and Exchange Commission for additional information on these factors and other factors that could cause actual results to differ materially from the forward-looking statements. FEI assumes no duty to update forward-looking statements.
For more information, please click here
Contacts:
FEI Company
Fletcher Chamberlin
Treasurer & Communications Director
(503) 726-7710
Copyright © FEI Company
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
Imaging
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Tools
Turning up the signal November 8th, 2024
Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom September 13th, 2024
Faster than one pixel at a time – new imaging method for neutral atomic beam microscopes developed by Swansea researchers August 16th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
Acquisitions/Mergers/Splits
180 Degree Capital Corp. Life Science Portfolio Company Enters Into Definitive Agreement to be Acquired May 6th, 2020
180 Degree Capital Corp.’s Portfolio Company, Synacor, Inc., Agrees to Merge with Qumu Corporation in All-Stock Transaction February 11th, 2020
Combination of Nanometrics and Rudolph Technologies to Create Onto Innovation October 16th, 2019
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||